Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences Solutions
  • Healthcare Solutions
  • Medical Device and Diagnostic
  • U.S. Government
Life Sciences Solutions

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences Solutions
Healthcare Solutions

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare Solutions
Medical Device and Diagnostic Solutions

Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.

Learn More
Medical Device and Diagnostic Solutions
U.S. Government Solutions

For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.

Learn More
U.S. Government Solutions
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

FEATURED WEBINAR

"Top Issues for Pharma to Watch in 2022 and 2023

WATCH NOW
MAIN/Contact Us
Contact Us/
Blog
The Role of Patient Organizations in Accelerating Innovation in Patient Care Through Artificial Intelligence – Pt. 3
Benefits of AI
Harvey Jenner, Principal, Healthcare Solutions, IQVIA
Matt Hackenberg, Associate Principal, Predictive Analytics, IQVIA
Alexandra Weiss Roeser, Director, Non-profit Strategy, Patient Advocacy, IQVIA
Oct 26, 2023
  • Locations
  • United States
  • US Blogs
  • The Role of Patient Organizations in Accelerating Innovation in Patient Care Through Artificial Intelligence – Pt. 3

In part three of our blog series, we focus on ways patient organizations can help overcome barriers and play an essential role in the adoption and use of artificial intelligence (AI) to improve outcomes for patients. Read PT. 2 of the blog series.

How patient organizations can help overcome barriers

With their extensive networks and unwavering commitment to patient wellbeing, care, and outcomes, patient organizations emerge as invaluable allies in navigating these challenges. Their insights, collaborations, and advocacy can play a pivotal role in ensuring that AI realizes its full potential in healthcare. The following are a sampling of ways patient organizations can help overcome barriers and play an essential role in the adoption and use of AI to improve outcomes for patients.

Funding support

Patient organizations are in a unique position where they can invest in areas that are not currently being served well, or are underserved, where traditional grant making mechanisms aren't available because government funding or commercially led interests don't align. The groups can prioritize patient needs in these areas with their funding decisions and diversify their research and grant strategies to enable these initiatives, building new kinds of partnerships outside of their traditional area of expertise. Thus, they can fund innovative initiatives such as AI through their own grant mechanisms.

In addition, given their strong convening power, there are opportunities to seek funding from external stakeholders to fund the development of novel algorithms, such as pharmaceutical companies with common interests.

Data access

Patient organizations can play a key role when it comes to data access. Often these organizations themselves sit upon a wealth of information in the form of their patient data initiatives. This data can be used alone as a foundation for the model development or can be used in conjunction with other data. For example, in rare diseases, registry data can be used to complement other datasets to confirm the diagnosis of rare diseases where ICD 10 codes alone are not sufficient to identify patients.

In addition, given the strong convening power of these organizations, patient organizations can convene with the physician networks they engage with to provide data into these AI programs. They also can form partnerships with other healthcare providers (HCPs), research institutions, or other organizations to provide access to broader and more diverse datasets for AI development.

Demystifying AI and elevating provider education

With their extensive networks and credibility, patient organizations are uniquely positioned to leverage their distribution channels to highlight AI's benefits, address adoption challenges, and foster clinician education and trust. They can drive AI's transformative potential in healthcare by dispelling misconceptions, showcasing ROI opportunities, and aiding in the seamless integration of new technologies into traditional systems.

Support implementation

By leveraging their reputation and reach, patient organizations can bridge the gap between AI-driven insights and practical implementation. They lend legitimacy to guidelines and practice standards, addressing clinician concerns about the underlying drivers of new care delivery models. Their credibility ensures that interventions, even those funded by pharmaceutical entities, are viewed with trust, especially if aligned with the organization's goals.

By tailoring documentation to the appropriate audience and sharing AI findings among clinicians, experts, and regulators, they can foster collaborations that integrate these insights into the latest clinical guidelines. Tangible examples include updating guidelines, publishing, and disseminating findings, and creating clinical decision support tools. Their role in facilitating education and awareness campaigns ensures medical professionals understand and embrace AI's benefits. Additionally, they can arm patients with these resources and educational tools to guide HCP interactions.

Patient organizations also play a pivotal role in successfully integrating these AI-driven tools and insights into healthcare workflows. Successful AI workflow integration requires a holistic approach that combines technical expertise, effective communication, and a commitment to ongoing improvement. Through dedicated and targeted efforts, they can adeptly navigate the challenges tied to AI adoption, fortify trust in AI technologies, and ultimately elevate the quality of patient care delivery.

To learn more about how IQVIA can help you with AI, contact us at pr-contact@iqvia.com.

Read the next chapter in the Role of Patient Organizations Series

Part four of this blog series focuses on ways patient organizations can help overcome barriers and play an essential role in the adoption and use of AI to improve outcomes for patients.

Read PT. 4

Related solutions

Contact Us